BIOQUAL, Inc., a Delaware corporation (“Issuer”), has filed an application with the Securities and Exchange Commission (“Commission”), pursuant to section 12(d) of the Securities Exchange Act of 1934 (“Act”)  and Rule 12d2-2(d) thereunder, to withdraw its Common Stock, $.01 par value (“Security”), from listing and registration on the Chicago Stock Exchange, Inc. (“CHX” or “Exchange”).
The Issuer states in its application that it has met the requirements of the CHX Article XXVIII, Rule 4, by complying with Exchange's rules governing an issuer's voluntary withdrawal of a security from listing and registration. In making the decision to withdraw the Security from listing and registration on the CHX, the Issuer considered (i) the cost associated with maintaining such listing and (ii) the Security's low trading volume. The Issuer determined that the benefits of continued listing of the Security on the Exchange did not justify the expense of maintaining such listing. Issuer stated that the Security is currently quoted on the OTC Bulletin Board.
The Issuer's application relates solely to the Security's withdrawal from listing on the CHX and from registration under section 12(b) of the Act  and shall not affect it obligation to be registered under section 12(g) of the Act.
Any interested person may, on or before May 2, 2002, submit by letter to the Secretary of the Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon whether the application has been made in accordance with the rules of the CHX and what terms, if any, should be imposed by the Commission for the protection of investors. The Commission, based on the information submitted to it, will issue an order granting the application after the date mentioned above, unless the Commission determines to order a hearing on the matter.Start Signature
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
Jonathan G. Katz,
[FR Doc. 02-9479 Filed 4-17-02; 8:45 am]
BILLING CODE 8010-01-P